Stocks › CDNA
CareDx CDNA
$70.00 −$1.92 (-2.67%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $69.79 -0.30%
Open$70.56
Prev close$71.92
Day range$69.26 – $72.94
Volume782.0K
Market cap$3.68B
P/E (TTM)29.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$139.36M+39.3% YoY
Operating profit$8.11M+3,397.6% YoY
Net profit$19.29M+1,051.8% YoY
Diluted EPS$0.35+1,066.7% YoY
Free cash flow$11.10M-68.6% YoY
Operating cash flow$12.72M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin71.0%
Operating margin0.8%
Net margin25.9%
Return on equity33.0%
Return on assets24.0%
Return on invested capital29.7%
Current ratio2.31
Liabilities / assets27.1%
Cash & investments$250.48M
Total debt$20.32M
Net cash (debt)$230.16M
Free cash flow / sales12.0%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $139.36M | $131.95M | $117.70M | $379.81M | $108.39M |
| Total Operating Revenue | $139.36M | $131.95M | $117.70M | $379.81M | $108.39M |
| Cost of Revenue | $40.29M | $34.97M | $33.63M | $123.24M | $35.51M |
| Gross Profit | $99.08M | $96.98M | $84.07M | $256.57M | $72.87M |
| Operating Expense | $90.96M | $96.73M | $82.27M | $281.64M | $78.91M |
| Selling and Admin Expenses | $69.64M | $74.35M | $60.86M | $210.21M | $59.61M |
| -Selling & Marketing Expense | $31.65M | $33.44M | $30.37M | $102.64M | $30.92M |
| -General & Admin Expense | $37.99M | $40.91M | $30.48M | $107.57M | $28.68M |
| Research & Development | $21.32M | $22.38M | $21.42M | $71.43M | $19.31M |
| Operating Profit | $8.11M | $257,000.00 | $1.80M | -$25.07M | -$6.04M |
| Net Non-Operating Interest Income (Expense) | $2.21M | $1.74M | $1.91M | $9.17M | $2.01M |
| Non-Operating Interest Income | $2.21M | $1.74M | $1.91M | $9.17M | $2.01M |
| Other Income (Expense) | $372,000.00 | $112.53M | -$930,000.00 | -$5.19M | $264,000.00 |
| Special Income (Charges) | $0.00 | $112.97M | -$600,000.00 | -$5.71M | $0.00 |
| -Gain on Sale Of Business | $0.00 | $112.97M | – | – | – |
| Other Non-Operating Income (Expenses) | $372,000.00 | -$440,000.00 | -$330,000.00 | $524,000.00 | $264,000.00 |
| Pretax Profit | $10.69M | $114.52M | $2.78M | -$21.08M | -$3.76M |
| Tax | -$8.60M | $3.88M | -$32,000.00 | $271,000.00 | $345,000.00 |
| Net Profit | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| Profit from Continuing Operations | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| Net Income to Parent Company | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| Net Income to Common Stockholders | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| Basic EPS | $0.37 | $2.15 | $0.05 | -$0.40 | -$0.08 |
| Diluted EPS | $0.35 | $2.07 | $0.05 | -$0.40 | -$0.08 |
| -Less:Other Special Charges | – | – | $600,000.00 | $5.71M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $641.46M | $532.99M | $411.06M | $413.23M | $413.23M |
| Total Current Assets | $321.30M | $429.22M | $269.40M | $257.13M | $257.13M |
| Cash and Cash Equivalents & Short-Term Investments | $250.48M | $373.64M | $187.18M | $177.21M | $177.21M |
| -Cash and Cash Equivalents | $250.48M | $373.64M | $77.92M | $65.43M | $65.43M |
| -Short Term Investments | $0.00 | $0.00 | $109.25M | $111.78M | $111.78M |
| Receivables | $47.73M | $34.38M | $44.59M | $42.63M | $42.63M |
| -Accounts Receivable | $47.73M | $34.38M | $44.59M | $42.63M | $42.63M |
| Inventory | $9.14M | $6.98M | $26.40M | $26.71M | $26.71M |
| Other Current Assets | $13.94M | $14.23M | $11.23M | $10.59M | $10.59M |
| Total Non-Current Assets | $320.16M | $103.77M | $141.67M | $156.10M | $156.10M |
| Net PPE | $50.55M | $43.04M | $54.36M | $55.73M | $55.73M |
| -Gross PPE | $50.55M | $43.04M | $54.36M | $94.58M | $94.58M |
| Investments and Advances | $0.00 | $0.00 | $10.90M | $24.17M | $24.17M |
| -Held to Maturity Securities | $0.00 | – | – | – | – |
| Goodwill and Other Intangible Assets | $261.49M | $54.52M | $72.44M | $72.30M | $72.30M |
| -Goodwill | $121.71M | $35.97M | $40.34M | $40.34M | $40.34M |
| -Other Intangible Assets | $139.78M | $18.56M | $32.10M | $31.96M | $31.96M |
| Other Non-Current Assets | $8.12M | $6.20M | $3.97M | $3.90M | $3.90M |
| Total Liabilities | $174.00M | $107.39M | $97.53M | $110.13M | $110.13M |
| Total Current Liabilities | $138.98M | $93.70M | $79.15M | $89.85M | $89.85M |
| Payables | $10.81M | $9.49M | $9.07M | $9.99M | $9.99M |
| -Accounts Payable | $10.81M | $9.49M | $9.07M | $9.99M | $9.99M |
| Current Accrued Expenses | $55.61M | $28.51M | $29.37M | $27.09M | $27.09M |
| Short-Term Debt and Capital Lease Obligation | $8.69M | $6.05M | $6.66M | $6.52M | $6.52M |
| -Current Capital Lease Obligation | $8.69M | $6.05M | $6.66M | $6.52M | $6.52M |
| Current Provisions | $16.37M | $9.53M | $7.95M | $3.50M | $3.50M |
| Current Deferred Liabilities | $6.95M | $5.55M | $5.56M | $4.65M | $4.65M |
| Total Non-Current Liabilities | $35.03M | $13.69M | $18.37M | $20.28M | $20.28M |
| Long Term Debt and Capital Lease Obligation | $20.32M | $13.20M | $17.84M | $19.68M | $19.68M |
| -Long Term Capital Lease Obligation | $20.32M | $13.20M | $17.84M | $19.68M | $19.68M |
| Non-Current Deferred Liabilities | $536,000.00 | $86,000.00 | $130,000.00 | $181,000.00 | $181,000.00 |
| Other Non-Current Liabilities | $14.17M | $406,000.00 | $407,000.00 | $418,000.00 | $418,000.00 |
| Total Equity | $467.46M | $425.60M | $313.54M | $303.10M | $303.10M |
| Stockholders' Equity | $467.46M | $425.60M | $313.54M | $303.10M | $303.10M |
| Capital Stock | $52,000.00 | $51,000.00 | $51,000.00 | $50,000.00 | $50,000.00 |
| -Common Stock | $52,000.00 | $51,000.00 | $51,000.00 | $50,000.00 | $50,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $953.56M | $930.99M | $1.05B | $1.04B | $1.04B |
| Retained Earnings | -$486.15M | -$505.45M | -$732.55M | -$735.36M | -$735.36M |
| Gains/Losses Not Affecting Retained Earnings | $0.00 | $0.00 | -$6.27M | -$5.52M | -$5.52M |
| -Accumulated Depreciation | – | – | – | -$38.85M | -$38.85M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $12.72M | $30.60M | $4.33M | $42.03M | $21.36M |
| Net cash flow from continuing operations | $12.72M | $30.60M | $4.33M | $42.03M | $21.36M |
| Net Income from Continuing Operations | $19.29M | $110.64M | $2.81M | -$21.35M | -$4.11M |
| Gain/Loss from Continuing Operations | $0.00 | -$112.88M | $119,000.00 | $48,000.00 | – |
| Depreciation & Depletion & Amortization | $9.07M | $4.05M | $5.32M | $20.42M | $5.26M |
| Other Non-Cash Items | -$9.41M | $51,000.00 | $15,000.00 | $703,000.00 | $108,000.00 |
| Change in Working Capital | -$15.88M | $17.59M | -$14.64M | $3.81M | $12.17M |
| -Change in Receivables | -$8.98M | $2.04M | -$2.08M | $22.52M | $5.31M |
| -Change in Inventory | -$841,000.00 | $2.27M | -$346,000.00 | -$4.96M | $2.03M |
| -Change in Prepaid Assets | $1.51M | -$5.50M | -$2.88M | -$4.41M | $3.95M |
| -Change in Payables and Accrued Expense | -$6.97M | $19.23M | -$7.78M | -$3.35M | $3.37M |
| -Change in Other Current Liabilities | -$2.00M | -$1.40M | -$1.56M | -$6.00M | -$1.54M |
| -Change In Other Working Capital | $1.40M | – | – | – | – |
| Net cash flow from investing | -$147.88M | $280.59M | $11.06M | $2.16M | -$34.91M |
| Net Cash Flow from Continuing Investing Activities | -$147.88M | $280.59M | $11.06M | $2.16M | -$34.91M |
| Capital Expenditure | -$1.62M | – | – | -$5.91M | -$1.97M |
| Net Business Purchase and Sale | -$145.77M | – | – | $0.00 | $0.00 |
| Net Investment Purchase and Sale | -$500,000.00 | $117.65M | $14.88M | $8.75M | -$32.94M |
| Financing Cash Flow | $12.90M | -$15.50M | -$2.91M | -$93.39M | -$12.46M |
| Net Cash Flow from Continuing Financing Activities | $12.90M | -$15.50M | -$2.91M | -$93.39M | -$12.46M |
| Net Common Stock Issuance | $0.00 | – | – | -$87.77M | -$12.21M |
| Proceeds from Stock Option Exercised | $17.47M | $2.75M | $1.10M | $8.00M | $1.41M |
| Net Other Financing Charges | -$4.57M | -$6.02M | -$4.01M | -$13.62M | -$1.67M |
| Ending Cash Balance | $251.89M | $374.16M | $78.47M | $65.98M | $65.98M |
| Net Change in Cash | -$122.27M | $295.69M | $12.48M | -$49.20M | -$26.01M |
| Beginning Cash Balance | $374.16M | $78.47M | $65.98M | $115.27M | $91.99M |
| Effect of Exchange Rate Changes | $0.00 | -$9,000.00 | $13,000.00 | -$90,000.00 | $6,000.00 |
| Free Cash Flow | $11.10M | $28.75M | $514,000.00 | $35.44M | $19.39M |
| Net PPE Purchase and Sale | – | – | -$3.82M | – | – |
| Deferred Tax | – | – | – | $17,000.00 | – |
| Net Intangibles Purchase and Sale | – | – | – | -$675,000.00 | $0.00 |
No comments yet — be the first to weigh in on CDNA.
Sign in to join the discussion.